B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only.
- Positions
- 18
- No filing for Q3 2024
- Portfolio value
- $163.6M
- No filing for Q3 2024
B Group, Inc. did not file a 13F for Q3 2024, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Invesco QQQ Tr46090E953 | PUT | 110,000 | $56.2M | 34.4% | – | – | – |
| ADMAAdma Biologics, Inc. | COM | 2,287,542 | $39.2M | 24.0% | – | – | History |
| INSMINSMED Inc | COM PAR $.01 | 350,000 | $24.2M | 14.8% | – | – | History |
| ZLABZai Lab Ltd | ADR | 400,000 | $10.5M | 6.4% | – | – | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 992,000 | $7.34M | 4.5% | – | – | History |
| AKROAkero Therapeutics, Inc. | COM | 260,000 | $7.23M | 4.4% | – | – | History |
| CLLSCellectis S.A. | SPON ADS | 3,081,501 | $5.55M | 3.4% | – | – | History |
| AURAAura Biosciences, Inc. | COM | 472,576 | $3.88M | 2.4% | – | – | History |
| SGHTSight Sciences, Inc. | COM | 629,370 | $2.29M | 1.4% | – | – | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 965,556 | $1.67M | 1.0% | – | – | History |
| Ultragenyx Pharmaceutical IN90400D908 | CALL | 29,500 | $1.24M | 0.8% | – | – | – |
| SYRESpyre Therapeutics, Inc. | COM NEW | 50,000 | $1.16M | 0.7% | – | – | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 50,651 | $799.3K | 0.5% | – | – | History |
| APGEApogee Therapeutics, Inc. | COM | 15,000 | $679.5K | 0.4% | – | – | History |
| Corvus Pharmaceuticals Inc221015950 | PUT | 100,000 | $535.0K | 0.3% | – | – | – |
| BNTXBioNTech SE | SPONSORED ADS | 3,500 | $398.8K | 0.2% | – | – | History |
| ORKAOruka Therapeutics, Inc. | COM | 20,000 | $387.8K | 0.2% | – | – | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 7,596 | $319.6K | 0.2% | – | – | History |